PI
MYGN icon

Putnam Investments’s Myriad Genetics MYGN Stock Holding History

Putnam Investments’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-58,340
Closed -$1.78M – 1316
2016
Q2 		$1.78M Sell
58,340
-15,596
-21% -$542K ﹤0.01% 964
2016
Q1 		$2.77M Sell
73,936
-88,257
-54% -$3.33M 0.01% 859
2015
Q4 		$7M Sell
162,193
-1,629
-1% -$68.8K 0.02% 558
2015
Q3 		$6.14M Sell
163,822
-175
-0.1% -$6.21K 0.01% 599
2015
Q2 		$5.57M Buy
163,997
+10,202
+7% +$347K 0.01% 689
2015
Q1 		$5.44M Sell
153,795
-1,595
-1% -$57.1K 0.01% 754
2014
Q4 		$5.29M Sell
155,390
-70,304
-31% -$2.49M 0.01% 756
2014
Q3 		$8.71M Sell
225,694
-3,351
-1% -$125K 0.02% 530
2014
Q2 		$8.91M Buy
229,045
+96,120
+72% +$3.58M 0.02% 519
2014
Q1 		$4.54M Sell
132,925
-1,065
-0.8% -$33K 0.01% 796
2013
Q4 		$2.81M Sell
133,990
-19,300
-13% -$488K 0.01% 955
2013
Q3 		$3.6M Hold
153,290
– – 0.01% 855
2013
Q2 		$4.12M Buy
+153,290
New +$4.44M 0.01% 784

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Putnam Investments's MYGN Position: Q3 2016 in Review

Putnam Investments sold out of Myriad Genetics (MYGN) in Q3 2016, closing a stake of 58,340 shares — an estimated $1.78M sold.

Putnam Investments first reported a position in MYGN in Q2 2013 and held it in 13 quarters. The position peaked at $8.91M in Q2 2014. 223 funds tracked by Wall St. Rank hold MYGN as of Q3 2016.

  • Putnam Investments reported no remaining Myriad Genetics position as of Q3 2016 after selling out during the quarter.
  • Putnam Investments sold 58,340 Myriad Genetics shares in Q3 2016, an estimated $1.78M.
  • Putnam Investments first reported a position in Myriad Genetics in Q2 2013 and held it in 13 quarters.
  • Putnam Investments's Myriad Genetics position peaked at $8.91M in Q2 2014.
  • 223 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2016.

Based on Putnam Investments's 13F filing for Q3 2016, filed 14 Nov 2016.